Assessment of Liver Function for Evaluation of Short- and Long-Term Outcomes in Type B Aortic Dissection Patients Undergoing Thoracic Endovascular Aortic Repair

被引：11

作者：

Liu, Jitao ^{[1
]}

Wu, Min ^{[2
]}

Xie, Enmin ^{[3
]}

Chen, Lyufan ^{[4
]}

Su, Sheng ^{[3
]}

Zeng, Hongke ^{[5
]}

Geng, Qingshan ^{[1
]}

Yang, Fan ^{[5
]}

Luo, Jianfang ^{[1
,3
]}

机构：

[1] Guangdong Acad Med Sci, Guangdong Prov Key Lab Coronary Heart Dis Prevent, Guangdong Prov Peoples Hosp, Dept Cardiol,Guangdong Cardiovasc Inst, Guangzhou, Peoples R China

[2] Guangdong Acad Med Sci, Dept Cardiac Surg, Guangdong Cardiovasc Inst, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China

[3] Southern Med Univ, Sch Clin Med 2, Guangzhou, Peoples R China

[4] South China Univ Technol, Sch Med, Guangzhou, Peoples R China

[5] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Dept Emergency & Crit Care Med, Guangzhou, Peoples R China

来源：

FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷

关键词：

type B aortic dissection; thoracic endovascular aortic repair; liver function; mortality; aspartate transaminase to platelet ratio index; model of end-stage liver disease; albumin-bilirubin score; CONSUMPTIVE COAGULOPATHY; CARDIAC-SURGERY; MORBIDITY; MORTALITY; MODEL; MELD;

D O I：

10.3389/fcvm.2021.643127

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background and Aims: Patients with decreased liver function suffer from poor outcomes when undergoing procedures. We aimed to explore the impact of liver fibrosis identified by aspartate transaminase-to-platelet ratio index (APRI) and poor liver functional reserve assessed by a model of end-stage liver disease (MELD) and albumin-bilirubin(ALBI) score on the prognosis of patients with type B aortic dissection (TBAD) undergoing thoracic endovascular aortic repair (TEVAR). Methods: A retrospective analysis of a prospectively maintained database from 2010 to 2017 was performed. APRI > 0.5 was used to identify those with significant liver fibrosis. Logistic and Cox regression analyses were performed to investigate the association between liver fibrosis, MELD, and ALBI with adverse events. Results: TEVAR was performed on 812 TBAD patients including 35 with liver fibrosis and 777 without. Twenty-four (3.0%) patients deceased during hospitalization and 69 (8.8%) patients died after a median 48.2 months follow-up. Multivariable analysis revealed that liver fibrosis, MELD, and ALBI were independently associated with in-hospital [fibrosis: odds ratio (OR) 23.73, 95% confidence interval (CI) 8.89-63.33, P < 0.001; MELD: OR 1.08, 95% CI 1.03-1.14, P = 0.003; ALBI: OR 4.45; 95% CI 1.56-12.67, P = 0.005] and follow-up mortality [fibrosis: hazard ratio (HR) 4.69, 95% CI 1.93-11.42, P = 0.001; MELD: HR 1.07, 95% CI 1.04-1.10, P < 0.001; ALBI: HR 2.88, 95% CI 1.53-5.43, P = 0.001]. The association was further corroborated by a subgroup analysis. Conclusion: Liver fibrosis and poor liver functional reserve could significantly increase the morbidity and mortality after TEVAR. APRI, MELD, and ALBI should be calculated and routinely used for preoperative risk stratification. Strict preoperative preparation and elaborate postoperative care are necessary to improve these patients' prognosis.

引用

页数：8

共 20 条

[1] Liver Abnormalities in Cardiac Diseases and Heart Failure [J].